Latest Southeast Asia News

Adrad Holdings delivered a 15% rise in net profit after tax for FY26, driven by operational efficiency and growth in engineered heat transfer solutions, alongside a 15% dividend increase.

Macmahon Holdings delivered a tenth consecutive year of growth with revenue up 7.9% to $2.6 billion and net profit after tax soaring 36.8% to $101.1 million, underpinned by strong contract wins and operational discipline.

Vita Life Sciences delivered a robust first half in 2026 with revenue up 6.1% to A$48.3 million and net profit after tax rising 14.9% to A$5.54 million. The company declared a higher interim dividend, reflecting improved margins and regional market momentum.

BlueScope Steel posted a remarkable 857% jump in reported NPAT to $802 million for FY2026, underpinned by strong US spreads, cost discipline, and growth in value-added steel products. The company declared record dividends and advanced key decarbonisation projects, signaling a confident transition from investment to shareholder returns.

Ovanti Limited is raising up to A$2.293 million through a 1-for-1 entitlement offer priced at $0.002 per share, marking a significant capital boost at a notable discount to recent trading.

SportsHero Limited has inked a deal with Razer to offer over 1,000 gaming-related digital products via its HeroPlay platform, broadening its reach beyond mobile subscriptions into consoles and PCs across Southeast Asia.

Ovanti Limited is set to raise approximately $1 million through a 500 million share placement priced at $0.002 each, with part of the raise pending shareholder approval.

ReNerve Limited has gained marketing approval for its flagship NervAlign Nerve Cuff in India, marking a critical milestone in its global expansion and enabling commercial rollout in one of the world's largest nerve repair markets.

De.mem Limited is poised for a record 2026, driven by 29 consecutive quarters of cash receipts growth, positive operating cashflow, and strategic expansion into the gold mining sector through Core Chemicals.

ReNerve has secured marketing approval for its NervAlign® Nerve Cuff in the Philippines, tapping into a major Southeast Asian market with significant nerve injury demand.

Dimerix CEO Dr Nina Webster detailed the company’s geographic and product diversification at the Bioshares Summit, spotlighting the commercial potential of DMX-200 and the newly acquired Phase 2 asset DMX-652 targeting acute kidney injury.

Vmoto Limited’s 2Q26 sales soared 156% year-on-year with strong international orders and strategic partnerships, including a global MotoGP deal and a joint venture in Thailand.